Joshua L. Eisenson

Joshua Eisenson is an associate in Goodwin’s Technology Companies and Life Sciences group. He advises emerging growth companies throughout their corporate lifecycle by supporting their commercial and legal needs from formation to exit. Mr. Eisenson specializes in working closely with cutting-edge companies on a diverse range of critical transactions, including seed, venture and growth equity financings, mergers and acquisitions, and corporate governance. His representations range across a variety of industries, including digital media, fintech, healthcare tech, cannabis, fashion and beauty, mobile, enterprise software, fitness, medical device and biotech.

Mr. Eisenson also represents venture capital and other strategic investors, advising them on structuring and executing their investment transactions and portfolio dispositions.